On July 2, the FDA also approved a look-alike competitor, Kisunla. Case closed, many scientists have argued, although drugs ...
that target one contributor to Alzheimer’s — sticky amyloid plaque buildup in the brain. Questions remain about which ...
Click here to get the story. 3. FDA approves new drug for Alzheimer’s disease Eli Lilly’s Kisunla (donanemab) is a monthly injection for adults with early symptomatic Alzheimer’s disease. Doctors ...
According to the Alzheimer's Association, more than 129,000 people aged 65 and older have Alzheimer's disease in Tennessee.
Chances are you or someone you know has been impacted by Alzheimer's disease. This week, the FDA approved a new drug that can ...
Doctors at the Roskamp Institute aim to treat around 10,000 patients a year with the new drugs and provide resources to area ...
The Food and Drug Administration recently approved a new drug called 'Donanemab' to treat the debilitating Alzheimer's ...
Jake Mintz and Jordan Shusterman dig into what is going wrong with the Yankees, who was selected as an All-Star starter and ...
For Dr. Jeffrey Cummings, a brain health researcher and professor at UNLV, this is an exciting time in the fight against Alzheimer’s disease. Federal health advisers in May voted to ...
Johns Hopkins Medicine study finds targeting the Aplp1 and Lag3 interaction could slow the progression of Parkinson’s and ...
The FDA has approved Kisunla, a new drug for early-stage Alzheimer’s Disease, marking a significant breakthrough in treatment ...
Wegovy and Novo's diabetes drugs Ozempic and Rybelsus all contain the same active ingredient, semaglutide, and belong to a ...